Skip to content

Intraperitoneal Gas Drainage to Reduce Postoperative Shoulder Pain After Gynecologic Laparoscopy .

Effect of Intraperitoneal Gas Drain on Postoperative Pain After Gynecologic Laparoscopy: A Randomized Controlled Trial.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07262749
Enrollment
124
Registered
2025-12-04
Start date
2025-12-01
Completion date
2027-01-01
Last updated
2025-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Shoulder Pain After Gynecologic Laparoscopy

Keywords

Laparoscopy, Shoulder Pain, Postoperative Pain, Carbon Dioxide Retention, Intraperitoneal Gas Drain, Gynecologic Surgery, Visual Analog Scale (VAS)

Brief summary

This randomized controlled trial aims to evaluate whether the use of an intraperitoneal gas drain at the end of gynecologic laparoscopic surgery can reduce postoperative shoulder pain. Residual carbon dioxide after laparoscopy is believed to irritate the diaphragm and cause referred shoulder pain, which is a common and distressing postoperative symptom. Women undergoing gynecologic laparoscopy lasting more than 20 minutes will be randomized to receive either an intraperitoneal drain for passive gas evacuation or standard care without a drain. Shoulder pain, abdominal pain, analgesic consumption, postoperative nausea and vomiting, and recovery indicators will be assessed during the first 48 hours after surgery.

Detailed description

Post-laparoscopic shoulder pain is a frequent complaint after gynecologic laparoscopy and is mainly attributed to residual carbon dioxide retained in the peritoneal cavity, which irritates the diaphragm and stimulates the phrenic nerve. This study is designed to investigate a simple mechanical intervention-placement of an intraperitoneal gas drain-to facilitate passive evacuation of carbon dioxide and potentially reduce postoperative pain. Women undergoing gynecologic laparoscopy lasting more than 20 minutes at the Department of Obstetrics and Gynecology, Women's Health University Hospital, Assiut University, will be recruited and randomized into two equal groups. The intervention group will receive a plastic intraperitoneal drain placed through the umbilical port and left in situ for 24 hours postoperatively. The control group will undergo standard gas evacuation without drain placement. Pain will be assessed using a 10-cm Visual Analog Scale (VAS) at recovery, 6, 12, 24, and 48 hours postoperatively for both shoulder and abdominal pain. Secondary outcomes include total analgesic consumption within 48 hours, incidence of postoperative nausea and vomiting, time to return of intestinal sounds, and time to first mobilization. The primary outcome is the mean shoulder pain score at 24 hours. This trial aims to provide high-quality evidence on the effectiveness of intraperitoneal gas drainage in reducing postoperative discomfort following gynecologic laparoscopy.

Interventions

OTHERIntraperitoneal Gas Drain

A plastic intraperitoneal drain is placed through the umbilical port at the end of laparoscopic surgery and left in situ for 24 hours to allow passive evacuation of carbon dioxide. This aims to reduce diaphragmatic irritation and postoperative shoulder pain.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Participants will be randomized into two parallel groups: one receiving intraperitoneal gas drainage and one receiving standard care without drainage.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women undergoing gynecologic laparoscopy lasting more than 20 minutes. * Able and willing to provide informed consent.

Exclusion criteria

* Refusal to participate. * Patients unable to give consent or unable to participate in pain assessment.

Design outcomes

Primary

MeasureTime frameDescription
Severity of postoperative shoulder pain using the Visual Analog Scale (VAS)At 24 hours after surgeryShoulder pain severity will be assessed using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.

Secondary

MeasureTime frameDescription
Postoperative shoulder pain (VAS) at 12 hoursAt 12 hours after surgeryPain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.
Postoperative shoulder pain (VAS) at 24 hoursAt 24 hours after surgeryPain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.
Postoperative shoulder pain (VAS) at 48 hoursAt 48 hours after surgeryPain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.
Postoperative shoulder pain (VAS) at 6 hoursAt 6 hours after surgeryPain severity will be measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate worse pain.
Incidence of postoperative nausea and vomitingUp to 48 hours after surgeryNumber of participants experiencing nausea and/or vomiting within 48 hours after surgery.
Time to return of bowel soundsUp to 48 hours after surgeryTime from end of surgery until the first documented return of bowel sounds.
Time to first mobilizationUp to 48 hours after surgeryTime from end of surgery until first ambulation.
Total analgesic consumption within 48 hoursUp to 48 hours after surgeryTotal amount of opioids and NSAIDs administered during the first 48 hours after surgery will be recorded.

Contacts

Primary ContactMohamed Shehata Mohamed Osman
Moha.shehata2016@gmail.com01015530934
Backup ContactAbdulrahmen Mohamed Rageh, MD
Abdulrahmanrageh@med.aun.edu.eg+20 100 505 6259

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026